CD19 and leukemia: Concerning the direct cytotoxic potential against CD19-expressing Sup-B15 in comparison to the non-target specific cytotoxicity against K562 leukemia cells, alpharetrovirally/RD114-TR generated CD19-CAR-NK cells displayed higher cell killing activity than lentivirally/VSV-G generated CD19-CAR-NK cells.